Industry reports claim that Phase I - IIIb clinical research accounts for over 35% of a drug’s development
cost and continues to be the source of some of the most painstaking delays. Sponsors are in a
constant search for ways to reduce these delays.

Coram Clinical Trials provides key project management and clinical services to support
Phase I - IIIb clinical trials in all major therapeutic areas. We’ve supported more than 40
leading manufacturers conduct over 130 clinical trials. Our experience covers many
types of medication delivery, including:

• Intravenous
• Injectable
• Oral
• Intranasal
• Topical
• Enteral